Key facts
- Land Medicine’s last known valuation is $120.0M (Jan 2025).
- It has raised $16.9M across 1 recorded rounds; the latest was Early Stage VC ($16.9M) in Dec 2024.
- Land Medicine has filed 1 Form D with the SEC, most recently Jan 2025 ($16.9M sold to 12 investors).
- Status: Privately Held (backing).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Land Medicine
Create free account
No card required
Funding rounds
1 roundsAbout Land Medicine
Developer of novel, cell-specific, in vivo gene editing technology designed for therapeutic research and development. The company is currently operating in Stealth mode.
- Sector
- Business Products and Services (B2B)
- HQ
- Charlestown, MA, United States
- Founded
- 2024
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
Land Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Land Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Land Medicine in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.